Abstract 1300: Identification of efficacious treatment for glioblastoma (GBM) by applying computational drug sensitivity imputation to novel GBM avatars and GBM clinical datasets
Danielle Maeser(University of Minnesota), Stephanie R. Huang(University of Minnesota), Frank B. Furnari(University of California San Diego), Clark C. Chen(Brown University), Robert F. Gruener(University of Minnesota), David A. Largaespada(Cincinnati Children's Hospital Medical Center), Robert Galvin(University of Minnesota), Tomoyuki Koga(University of Minnesota)
Cited by 1
Related Papers
Malignant astrocytic glioma: genetics, biology, and paths to treatment
|Genes & Development|2007|2.3k
oncoPredict: an R package for predicting <i>in vivo</i> or cancer patient drug response and biomarkers from cell line screening data
|Briefings in Bioinformatics|2021|1.8k
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
|Nature|2011|1.3k
Lymphotactin: a Cytokine that Represents a New Class of Chemokine
|Science|1994|662
Heterogeneity Maintenance in Glioblastoma: A Social Network
|Cancer Research|2011|435